What laboratory tests should be ordered to evaluate elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT)?

Laboratory Evaluation of Elevated AST and ALT

Order a comprehensive hepatocellular injury workup that includes viral hepatitis serologies (hepatitis A IgM, hepatitis B surface antigen and core antibody IgM, hepatitis C antibody), metabolic panel, complete blood count, and abdominal ultrasound as first-line investigations. 1, 2

Initial Laboratory Testing

The evaluation should be systematic and based on the pattern and degree of aminotransferase elevation:

Essential First-Line Tests

• Viral hepatitis panel: Hepatitis A IgM, HBsAg, HBcAgIgM, and HCV antibody (consider HCV-RNA if antibody positive) 3, 2
• Complete metabolic panel: Including alkaline phosphatase, bilirubin, albumin, and prothrombin time/INR to assess hepatic synthetic function 4
• Complete blood count: Platelet count and mean corpuscular volume (MCV) help differentiate causes and assess for cirrhosis 4
• Fasting lipid panel and glucose: To evaluate for metabolic syndrome and NAFLD risk 1

Calculate the AST:ALT Ratio

This ratio provides critical diagnostic information:

• AST:ALT >2: Suggests alcohol-induced liver disease (ratios >3 are highly suggestive) 1, 5
• AST:ALT <1: Suggests NAFLD or metabolic liver disease 1
• Predominantly elevated AST: Consider non-hepatic causes including hemolysis, myopathy, thyroid disease, or recent exercise 1

Severity-Based Approach

Mild Elevation (<5× Upper Limit Normal)

The most common causes are NAFLD and alcohol-induced liver disease 1. Additional testing should include:

• Alcohol use assessment: Detailed history including AUDIT questionnaire; GGT may support but has limited sensitivity/specificity 4, 5
• Iron studies: Serum ferritin and transferrin saturation to screen for hereditary hemochromatosis 1, 4
• Autoimmune markers: Antinuclear antibody (ANA), anti-smooth muscle antibody, immunoglobulins if autoimmune hepatitis suspected 4
• Ceruloplasmin: For Wilson disease screening, particularly in patients under 40 years 6, 4
• Alpha-1 antitrypsin level: Especially with family history or emphysema 1, 4
• Thyroid function tests: TSH to exclude hypothyroidism as non-hepatic cause 1

Moderate to Severe Elevation (≥5× Upper Limit Normal)

Requires more urgent and comprehensive evaluation:

• All tests listed above
• Immediate assessment for acute liver failure markers: coagulation studies, bilirubin fractionation, renal function 6
• Consider acute causes: Ischemic hepatitis, acute Budd-Chiari syndrome, drug-induced liver injury, acute viral hepatitis 1

Special Diagnostic Considerations

Wilson Disease Red Flags

If AST and ALT are elevated with any of the following, add 24-hour urinary copper and slit-lamp examination:

• Age <40 years with atypical presentation
• Coombs-negative hemolytic anemia
• Alkaline phosphatase:bilirubin ratio <2
• Relatively modest aminotransferase elevation (<2000 IU/L) with acute liver failure 6

Drug-Induced Liver Injury

Obtain comprehensive medication history including:

• Prescription medications
• Over-the-counter drugs
• Herbal supplements
• Dietary supplements 1, 7, 2

Imaging

Abdominal ultrasound is the appropriate first-line imaging study for mild aminotransferase elevations, with 84.8% sensitivity and 93.6% specificity for moderate-to-severe hepatic steatosis (>30% fat content) 1. Ultrasound also evaluates for:

• Biliary tract disease
• Focal liver lesions
• Signs of cirrhosis or portal hypertension
• Hepatic vein patency

Assessment of Fibrosis

For patients with chronic elevation (>6 months), non-invasive fibrosis assessment is essential since advanced fibrosis may present with normal liver enzymes 4:

• APRI score: (AST/ULN × 100)/platelet count; >1.5 suggests significant fibrosis, >2 suggests cirrhosis 8
• FIB-4 score: Age × AST/(platelet count × √ALT); <1.45 has 90% negative predictive value for advanced fibrosis, >3.25 has 65% positive predictive value 8
• Transient elastography: Cutoff 7.1-8.8 kPa for significant fibrosis (≥F2), 12.5-14.6 kPa for cirrhosis 8

Common Pitfalls to Avoid

• Don't rely on GGT alone for alcohol use diagnosis—it has poor sensitivity and specificity 4, 5
• Don't assume normal ALT excludes liver disease—true healthy normal is 29-33 IU/L for males and 19-25 IU/L for females 1, 2
• Don't overlook non-hepatic causes when AST is disproportionately elevated compared to ALT 1
• Don't delay evaluation in patients with elevated bilirubin or coagulopathy—these indicate more severe disease requiring expeditious workup 3

Follow-Up Strategy

If initial comprehensive workup is unremarkable with mild, persistent elevation:

• Close clinical follow-up with repeat liver chemistries every 3-6 months 3
• Consider liver biopsy if elevations persist beyond 6 months, worsen despite removing potential causes, or if multiple diagnoses are possible 9, 4, 3
• Reassess for occult causes: Medication review, alcohol consumption patterns, weight changes 9